EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. When pregnancy is detected, patients should discontinue EDARBI

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.